FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

SPOTLIGHT: Are costly cancer drugs worth the price?

Tools
Tags
clinicians

With price tags that can hit a mind-boggling $100,000 for an annual supply, critics are increasingly questioning whether certain cancer drugs are worth the price, particularly given that they may only extent a patient's life for a few months. policymakers and clinicians are asking whether society should invest such a large sum on patients who are about to die either way. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.